senicapoc
Small moleculeexperimental
Senicapoc (ICA-17043) is a Gardos channel blocker. — Wikipedia
Clinical trial activity
11 trials · 14 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
10
Phase 3
3
Phase 4
0
Earliest trial started Feb 1, 2002 (NCT00040677)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Loading structure…
SMILES
NC(=O)C(c1ccccc1)(c1ccc(F)cc1)c1ccc(F)cc1- Mol. weight
- 323.34 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaSenicapoc ↗
- ChEMBLCHEMBL405821 ↗
Also known as
- bis(4-fluorophenyl)phenylacetamide
- ica17043
- ica 17043
- ica-17043
- ica-17043
- ica-17043
- ica-17043
- pf-05416266
- pf-05416266
- senicapoc
- senicapoc
- senicapoc
- senicapoc
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07284069 | Early Phase 1 (Phase 1) | Feb 1, 2026 | Aarhus University, University of Copenhagen |
| NCT07282210 | Phase 2 | Jan 31, 2026 | Biossil Inc. |
| NCT06714123 | Phase 2 | Jan 31, 2025 | Region Syddanmark, University of Southern Denmark |
| NCT04804241 | Phase 2 | Jan 1, 2022 | University of California, Davis |
| NCT04372498 | Phase 3 | Jul 1, 2020 | Harvard University, Quest Diagnostics |
| NCT04594668 | Phase 2 | Apr 24, 2020 | Aalborg University, Aarhus University, University of Copenhagen, University of Southern Denmark |
| NCT00861185 | Phase 2 | Mar 1, 2009 | ICAgen |
| NCT00861211 | Phase 2 | Oct 1, 2008 | ICAgen, University of London |
| NCT00294541 | Phase 3 | Feb 1, 2006 | ICAgen, Johnson and Johnson |
| NCT00102791 | Phase 3 | Feb 1, 2005 | ICAgen, McNeil |
| NCT00040677 | Phase 2 | Feb 1, 2002 | ICAgen, University of North Carolina at Chapel Hill |
Showing 11 of 11 trials
Page 1 / 1
Organizations
Research & Development (14)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ICAgen | For profit | 5 | 5 | 2 | 2002 |
| Aarhus University | Academic/Hospital | 2 | 2 | 2 | 2020 |
| University of Copenhagen | Academic/Hospital | 2 | 0 | 2 | 2020 |
| University of Southern Denmark | Academic/Hospital | 2 | 0 | 1 | 2020 |
| Aalborg University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Biossil Inc. | For profit | 1 | 1 | 1 | 2026 |
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Johnson and Johnson | For profit | 1 | 0 | 1 | 2006 |
| McNeil | For profit | 1 | 0 | 1 | 2005 |
| Quest Diagnostics | For profit | 1 | 0 | 1 | 2020 |
| Region Syddanmark | Academic/Hospital | 1 | 1 | 1 | 2025 |
| University of California, Davis | Academic/Hospital | 1 | 1 | 1 | 2022 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2008 |
| University of North Carolina at Chapel Hill | Academic/Hospital | 1 | 0 | 1 | 2002 |
14 organizations
Page 1 / 1